SEC 13F Intelligence

Exome Asset Management LLC / LLY

Exome Asset Management LLC’s Eli Lilly & Co Position

Does Exome Asset Management LLC own Eli Lilly & Co (LLY)? Yes — 7.0K shares worth $6M (+3.34% of its 13F portfolio) as of Q1 2026, down from 7.9K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
7.0K
% of Portfolio
+3.34%
Quarters Held
10
currently held

Position History LLY

Reported value by quarter
Q4 ’23: $6MQ4 ’23Q1 ’24: $8MQ2 ’24: $9MQ2 ’24Q3 ’24: $9MQ4 ’24: $6MQ4 ’24Q1 ’25: $4MQ2 ’25: $4MQ2 ’25Q3 ’25: $6MQ4 ’25: $8MQ4 ’25Q1 ’26: $6Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20267.0K$6M+3.34%
Q4 20257.9K$8M+4.03%
Q3 20257.9K$6M+3.63%
Q2 20254.7K$4M+2.71%
Q1 20254.7K$4M+3.43%
Q4 20248.2K$6M+4.78%
Q3 202410.4K$9M+6.35%
Q2 20249.7K$9M+7.65%
Q1 20249.7K$8M+6.46%
Q4 20239.7K$6M+5.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exome Asset Management LLC’s full portfolio or all institutional holders of LLY.